OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

So my mother-in-law travels to Israel every year to stock up on a cannabis-based cream for her Rheumatoid Arthritis. CBD works on all sorts of ailments. It's not toxic.

When a new "drug" is tested by the FDA the first concern is to determine if the new drug is harmful. OWCP's products are going to breeze through that stage of testing. Then it goes to efficacy testing. The time spent at that stage is less about "does it work", and more about what ratio of CBD/THC is MOST effective.

In any event, look at the prices of pre clinical biotech companies that have one or two prospects in the pipeline. Those are valued on models that weigh likelihood of FDA approval, likely percent of market share, and scarcity of other medications for that particular ailment.

OWCP will have a complex valuation model because the pipeline is so robust.